Targeted Gene Therapy for Brain Tumor
Targeted Gene Therapy for Brain Tumor
批准号:
10470298
负责人:
HAMADA Hirofumi
金额:
$8.83万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Highly augmented cytopathic effect of a fiber-mutant E1B-defective adenovirus for gene therapy of glioma. Cancer Res., 1999. An E1B 55-kDa gene-defective adenovirus(Adv), ONYX-015, has been reported to be a highly useful replication-competent Adv that shows cytopathic effect for cancers with an abnormal p53 gene, without damaging normal tissues. In this study, we combined this Adv (Adv-E1Adb) with a fiber mutation, F/K20, which has a stretch of 20 lysine residues added at the COO-H-terminus of the fiber and shows high transduction efficiency to gliomas. In U-373 MG glioma cells, the transduction efficiency of Adv-F/K20 for lacZ was nine times higher than that of the Adv with wild-type fiber (Adv-F/wt) for lacZ. At a multiplicity of infection of 30, the replication efficiency of Adv-E1AdB-F/K20 was 11 times higher than that of Adv-E1AdB with wt fiber (Adv-E1AdB-F/wt). The ED50 value of AdvE1AdB-F/K20 to U-373 MG cells, which is a measure of the in vitro cytopathic effect, was 32 times g … More reater than that of Adv-E1AdB-F/wt. Injection of Adv-E1AdB-F/K20 suppressed the in vivo growth of tumors. The antitumoral effect of Adv-E1AdB-F/K20 was remarkably stronger than that of Adv-E1AdB-F/wt. A greater quantity of replicated virus protein (hexon) by infection with Adv-E1AdB-F/K20 was demonstrated in vitro and in vivo, compared with that of Adv-E1AdB-F/wt. In conclusion, gene therapy using Adv-E1AdB-F/K20, which drastically augmented the antitumoral effect of Adv-E1AdB, will be promising therapeutic approach for gliomas.Adenovirus-mediated transfer of p33ィイD1INGィエD1 with p53 drastically augments apoptosis in gliomas. Cancer Res., 1999. The p53 tumor suppressor gene is an important target for the gene therapy of cancers, and clinical trials targeting this gene have been conducted. Some cancers, however, are refractory to p53 gene therapy. Therefor, it has been combined with other therapies including chemotherapy and radiotherapy to enhance the cytopathic effect of p53 induction. The p33ィイD1ING1ィエD1 gene cooperates with p53 to block cell proliferation. In this study, we investigated whether adenovirus (Adv)-mediated co-induction of p33ィイD1ING1ィエD1 and p53 enhances apoptosis in glioma cells (U251 and U-373MG), which showed no genetic alterations but low expression levels of p33ィイD1ING1ィエD1. Co-infection of Adv-p33 and Adv-MBP-p53 at the same MOIs induced drastically enhanced apoptosis in both cell lines. Our results indicated that this co-infection approach can be used as a modality for the gene therapy of gliomas, sparing damage to normal tissues. Less
期刊论文(52)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Yoshida,Y., Sadata,A., Zhang,W., Shinoura,N., and Hamada,H.: "Generation of fiber-mutant recombinant adenoviruses for gene therapy of malignant glioma." Human Gene Therapy. 9(17). 2503-2515 (1998)
Yoshida,Y.、Sadata,A.、Zhang,W.、Shioura,N. 和 Hamada,H.:“用于恶性神经胶质瘤基因治疗的纤维突变重组腺病毒的生成。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Zhang,W., He L., Yuan Z., Xie Z., Wang,J., Hamada,H., and Cao X.: "Enhanced therapeutic efficacy of tumor RNA-pulsed dendritic cells after-genetic modification with lymphotactin." Human Gene Therapy. 10(7)in press. (1999)
张 W.、何 L.、袁 Z.、谢 Z.、王 J.、滨田 H. 和曹 X.:“用淋巴趋化素进行基因修饰后肿瘤 RNA 脉冲树突状细胞的治疗效果增强。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
TANAKA,H., YOSHIZAWA,H., YAMAGUCHI,Y., ITO,K., KAGAMU,H., SUZUKI,E., HAMADA,H., ARAKAWA,M.,: "Successful adoptive immunotherapy of murine nonimmunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cells."J. Immu
TANAKA,H., YOSHIZAWA,H., YAMAGUCHI,Y., ITO,K., KAGAMU,H., SUZUKI,E., HAMADA,H., ARAKAWA,M.,:“小鼠非免疫原性肿瘤的成功过继免疫治疗
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
SHINOURA,N., YOSHIDA,Y., ASAI,A., KIRINO,T., HAMADA,H.: "Relative level of expression of Bax and Bcl-XL determines the cellular fate of apoptosis/necrosis induced by the overexpression of Bax."Oncogene. 18(41). 5703-5713 (1999)
Shinoura,N.、YOSHIDA,Y.、ASAI,A.、KIRINO,T.、HAMADA,H.:“Bax 和 Bcl-XL 的相对表达水平决定了 Bax 过表达诱导的细胞凋亡/坏死的细胞命运
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 52 条
Reconsideration of the Position of "Professionality of Education" in New School Governance
-
批准号:15K13172
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.16万
-
财政年份:2015
-
负责人:HAMADA Hirofumi
-
依托单位:
A Study on the Characteristics of Japanese Style of School Leadership
-
批准号:23653238
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.25万
-
财政年份:2011
-
负责人:HAMADA Hirofumi
-
依托单位:
An Investigation of Supportive Functions of School Accreditation for School Improvement in the United States
-
批准号:21402040
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.57万
-
财政年份:2009
-
负责人:HAMADA Hirofumi
-
依托单位:
Organizational Factors to Facilitate the Function of "Self-Evaluation" within a School
-
批准号:18530589
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.84万
-
财政年份:2006
-
负责人:HAMADA Hirofumi
-
依托单位:
Targeted gene therapy for brain tumor
-
批准号:14370440
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.54万
-
财政年份:2002
-
负责人:HAMADA Hirofumi
-
依托单位:
A Comparative Study of the Change of School Management through the Establishment of "School-Site Autonomy" and the Role of Principals in the U. S. A. and Japan
-
批准号:13610277
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.73万
-
财政年份:2001
-
负责人:HAMADA Hirofumi
-
依托单位:
Targeted gene therapy for brain tumor
-
批准号:12470294
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.58万
-
财政年份:2000
-
负责人:HAMADA Hirofumi
-
依托单位:
Targeted gene therapy for malignant melanoma
-
批准号:12557071
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.32万
-
财政年份:2000
-
负责人:HAMADA Hirofumi
-
依托单位:
海外基金